Phase IB Study of Biomarker Modulation by Celecoxib vs. Placebo in Women With Newly-Diagnosed Breast Cancer.
Phase of Trial: Phase I
Latest Information Update: 21 Sep 2016
At a glance
- Drugs Celecoxib (Primary)
- Indications Breast cancer
- Focus Biomarker; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 15 Oct 2008 New trial record.